A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). (NCT07602582)
An Annual Dosing Study of Donanemab in Participants Who Completed Donanemab Study AACM
🩺 Plain-English Summary (8th-Grade Level)
The main purpose of this study is to determine if participants who previously took donanemab get clinical benefit when they receive annual doses. For each participant, the study will last up to 2.5 years and will include 6 visits.
Who can join: Review the eligibility criteria below.
Location: Banner Alzheimer's Institute — Phoenix, Arizona
Age range: 55 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (59 Sites)
Showing the first 25 of 59 sites.
- Banner Alzheimer's Institute — Phoenix, Arizona
- Care Access - Huntington Beach — Huntington Beach, California
- Irvine Clinical Research — Irvine, California
- Healthy Brain Clinic — Long Beach, California
- Artemis Institute for Clinical Research — Riverside, California
- Clinical Trials Research — Sacramento, California
- Artemis Institute for Clinical Research — San Diego, California
- Syrentis Clinical Research — Santa Ana, California
- Providence Medical Foundation — Santa Rosa, California
- Infectious Disease Doctors Medical Group, APC — Walnut Creek, California
- VIN - Aventura — Aventura, Florida
- Bradenton Research Center, Inc. — Bradenton, Florida
- Finlay Medical Research — Greenacres City, Florida
- Jacksonville Center for Clinical Research — Jacksonville, Florida
- K2 Medical Research ORLANDO — Maitland, Florida
- Merritt Island Medical Research, LLC — Merritt Island, Florida
- Finlay Medical Research — Miami, Florida
- VIN-Andrew Lerman — Miami, Florida
- Indago Research & Health Center, Inc — Miami Lakes, Florida
- Adult Medicine of Lake County, Inc. — Mt. Dora, Florida
- Suncoast Clinical Research, Inc. — New Port Richey, Florida
- Charter Research - Orlando — Orlando, Florida
- Headlands Research Orlando — Orlando, Florida
- Emerald Coast Neurology - Airport Boulevard — Pensacola, Florida
- Progressive Medical Research — Port Orange, Florida
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Alzheimer Disease
- The Use of Memantine for Prevention of Alzheimer's Disease — Charlottesville, Virginia
- Investigation of Inflammation Using [C-11]-CS1P1 — St Louis, Missouri
- Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia — Palo Alto, California
- A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) — Gilbert, Arizona
- High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease — Cambridge, Massachusetts
- A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease — Phoenix, Arizona
Explore by condition: All Alzheimer Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.